Thermo Fisher Scientific Information

In response to the novel coronavirus (SARS-CoV-2) outbreak, Thermo Fisher Scientific has worked rapidly to develop a new multiplex real-time RT-PCR diagnostic kit to enable clinical and public health laboratories to quickly diagnose COVID-19 caused by SARS-CoV-2 infection. The Applied Biosystems TaqPath COVID-19 Combo Kit is a fast, highly sensitive multiplex diagnostic solution that contains both the assays and controls needed for the real-time PCR detection of RNA from the SARS-CoV-2 virus.

The TaqPath COVID-19 Combo Kit consists of both the TaqPath RT-PCR COVID-19Kit and the TaqPath COVID-19 Control Kit for simplified ordering. Clinical laboratories can evaluate 94 specimens in under 3 hours, or 382 specimens in under 6.5 hours, with a single Thermo Scientific KingFisher purification system and Applied Biosystems real-time PCR system combination. When additional approved instruments are utilized, throughput can increase significantly. The kit is approved for use with RNA extracted from patients at risk of exposure to SARS-CoV-2 or with signs and symptoms of COVID-19 (see product label for Intended Use Statement and product information):

  • Bronchoalveolar lavage (BAL)

  • Mid-turbinate swabs

  • Nasal swabs

  • Nasopharyngeal swabs

  • Nasopharyngeal aspirate (nasal aspirate)

  • Oropharyngeal swabs

 

The TaqPath COVID-19 Combo Kit is a single, high-throughput (1,000 reactions) kit and is for use with an expanding range of Applied Biosystems real-time PCR instruments

  • Facebook

©2020 by Prism Health Lab.